Skip to content

A study on resistant fungal infection of the skin and its response to treatment used at present

Clinical and microbiological evaluation of Recalcitrant Dermatophytosis and antifungal susceptibility of Trichophyton mentagrophytes - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/068019
Enrollment
90
Registered
2024-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis Health Condition 2: B356- Tinea cruris

Interventions

Intervention1: NIL: NIL

Sponsors

Dr Sara Farooquie
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with recalcitrant dermatophytosis of the body and groin (active Tinea corporis and cruris infection with history of treatment with antifungal medications for atleast one month which did not get cured or recurred after stopping treatment.) 2.Patients willing to give consent for the study

Exclusion criteria

Exclusion criteria: 1. Tinea cases who have not received any treatment 2. Tinea infection involving scalp, nails, palms and soles 3. Pregnant and lactating patients. 4. Patients less than 18 years of age. 5. Patients not willing to give consent to be a part of the study.

Design outcomes

Primary

MeasureTime frame
Identification of species causing recalcitrant tinea and estimation of antifungal drug susceptibility of Trichophyton mentagrophytes to Itraconazole and TerbinafineTimepoint: 18 MONTHS

Secondary

MeasureTime frame
Clinical reponse of recalcitrant tinea to currenly used antifungal medicationTimepoint: This study measures clinical response at 2 weeks, 4 weeks and 6 weeks

Countries

India

Contacts

Public ContactSara Farooquie

Kasturba Medical College, Mangalore

deepti.dsouza@manipal.edu9964243781

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026